Migraines: Triggers, Treatment, and Prevention Strategies (2026)

Migraine is the second leading cause of disability worldwide — affecting roughly 1 billion people and causing more lost productive time than almost any other neurological condition. Yet migraine remains dramatically undertreated: surveys suggest only half of people with migraine have ever received a formal diagnosis, and fewer still receive optimal treatment. If you're losing days of your life to migraine, there are now more effective options than ever before.

What Is a Migraine — and Why It's Not "Just a Headache"

A migraine is a complex neurological event, not simply a bad headache. It involves changes in brain electrical activity, blood flow, and neurotransmitter levels — generating pain that's typically severe, often throbbing, and frequently accompanied by symptoms that a regular headache doesn't cause.

The International Headache Society (IHS) defines migraine as headache attacks lasting 4–72 hours with at least two of: unilateral location, pulsating quality, moderate or severe intensity, worsened by routine physical activity — plus at least one of: nausea/vomiting, or sensitivity to both light and sound. This distinguishes it from tension-type headache (which is usually bilateral, non-pulsating, and mild-moderate).

The Four Phases of a Migraine

Prodrome (1–2 days before): Warning signs — mood changes (depression or euphoria), food cravings, increased yawning, neck stiffness, increased urination. Recognizing this phase enables early treatment before the headache begins.

Aura (in ~25–30% of migraineurs): Reversible neurological symptoms developing over 5–20 minutes and lasting less than 60 minutes before the headache. Most commonly visual — zigzag lines, blind spots, flashing lights. Can also cause sensory (tingling), speech, or motor symptoms. Aura reflects a wave of electrical activity (cortical spreading depression) moving across the brain.

Headache phase: The main event — typically unilateral, pulsating pain that builds over 1–2 hours to peak intensity. Light (photophobia) and sound (phonophobia) sensitivity are hallmarks. Many migraineurs retreat to a dark, quiet room. Nausea is common; vomiting occurs in about 30%.

Postdrome ("migraine hangover"): After pain resolves, many people feel exhausted, "washed out," cognitive fog, and mood changes for up to 24–48 hours. This phase significantly extends migraine's total impact on function.

Common Migraine Triggers

Triggers are factors that lower the threshold for a migraine to occur in susceptible individuals. They don't cause migraine — they provoke it in people already biologically predisposed. Important: you may not react to a trigger every time, and combination of triggers often matters more than single triggers.

Acute Treatment: Stopping an Attack Fast

The Golden Rule: Treat Early

The single most impactful thing you can do during a migraine is treat it at the first sign — ideally in the prodrome or at the very onset of headache, before it reaches full intensity. Waiting for pain to become severe dramatically reduces medication effectiveness and prolongs the attack.

Step 1: Simple Analgesics (Mild-Moderate Attacks)

For mild-to-moderate attacks, non-prescription medications work well when taken early:

• Aspirin 900–1000mg — effective and underused for migraine; take with 10mg metoclopramide to enhance gastric emptying and absorption
• Ibuprofen 400–600mg — NSAID with good migraine evidence
• Naproxen sodium 500–550mg — longer duration, good for menstrual migraine
• Acetaminophen 1000mg — less effective than NSAIDs but useful when NSAIDs are contraindicated
• Excedrin Migraine (aspirin + acetaminophen + caffeine) — the combination is synergistic; well-evidenced

Step 2: Triptans (Moderate-Severe Attacks)

Triptans — 5-HT1B/1D serotonin receptor agonists — are the most effective class of prescription acute migraine treatments. They constrict dilated blood vessels and block pain signal transmission in the trigeminal system. Several are available:

• Sumatriptan — the original triptan; available oral, nasal spray, and subcutaneous injection (fastest and most powerful)
• Rizatriptan — fast onset (30–60 minutes); available as oral disintegrating tablet (convenient when nausea prevents swallowing)
• Eletriptan — excellent efficacy; longer duration of action
• Naratriptan/frovatriptan — slower onset, longer duration; useful for prolonged or menstrual migraines
• Zolmitriptan — nasal spray option available

All triptans are contraindicated in cardiovascular disease, uncontrolled hypertension, and hemiplegic/basilar migraine. They should not be used more than 2–3 days per week to avoid medication overuse headache.

Step 3: Newer Acute Treatments (2020–2026)

Gepants (CGRP receptor antagonists): Ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) are orally available small molecules that block the CGRP receptor — a key molecule in migraine pathophysiology. They have a major advantage over triptans: they don't cause vasoconstriction, making them safe for patients with cardiovascular disease. No medication overuse headache risk. Rimegepant uniquely shows both acute and preventive effects when taken every other day.

Ditans: Lasmiditan (Reyvow) — a selective 5-HT1F agonist. Doesn't constrict blood vessels; safe in cardiovascular disease. Causes dizziness and sedation — don't drive for 8 hours after use. Schedule IV controlled substance (potential for CNS effects).

Dihydroergotamine (DHE): A highly effective older medication — available as nasal spray (Migranal) or IV/IM in emergency settings. A newer nasal powder formulation (Trudhesa) has improved delivery and tolerability.

Migraine Prevention: When and What

Who Needs Preventive Therapy?

Consider preventive treatment if you have:

• 4 or more migraine days per month
• Attacks lasting more than 48 hours despite acute treatment
• Acute medication needed on more than 10–15 days per month
• Severe disability even with infrequent attacks
• Migraine with aura (stroke risk considerations)
• Specific migraine subtypes: hemiplegic migraine, brainstem aura, etc.

Traditional Preventive Medications

Beta-blockers — propranolol (most evidence) and metoprolol. Reduce migraine frequency by 40–50% in responders. Avoid in asthma, depression, and Raynaud's phenomenon. First-line option.

Valproate/topiramate — anticonvulsants with strong migraine prevention evidence. Topiramate 25–100mg daily; weight loss side effect is welcome for many patients but cognitive ("dopamax") and kidney stone effects limit use. Avoid valproate in women of reproductive age (teratogenic).

Amitriptyline/nortriptyline — low-dose tricyclic antidepressants. Particularly useful when migraine coexists with insomnia, depression, or chronic daily headache. Take at bedtime (10–75mg); drowsiness side effect minimized.

Candesartan — an ARB blood pressure medication with good evidence for migraine prevention and an excellent safety profile — less well-known but effective alternative.

CGRP Monoclonal Antibodies — The 2020s Revolution

Anti-CGRP monoclonal antibodies have transformed migraine prevention since 2018. They target the CGRP pathway specifically involved in migraine — offering dramatically better tolerability than older preventives and monthly or quarterly dosing:

In clinical trials, CGRP antibodies reduced monthly migraine days by 50% or more in approximately 50–60% of patients. They have an excellent safety profile — no liver monitoring needed, minimal drug interactions, no cognitive side effects. The main limitations: cost (significant; insurance coverage varies) and not all patients respond.

OnabotulinumtoxinA (Botox) — injected into 31 head and neck sites every 12 weeks. FDA-approved for chronic migraine (15+ migraine days/month). Highly effective for this subgroup — reduces monthly headache days by 7–9 days vs 6 with placebo in the PREEMPT trials.

Non-Drug Prevention: Neuromodulation Devices

Several FDA-cleared devices modulate nerve activity without medications — useful for patients who can't tolerate or don't want preventive medications:

• Cefaly — transcutaneous supraorbital nerve stimulator; worn on forehead 20 minutes daily for prevention. Multiple trials show efficacy
• GammaCore (Vagus Nerve Stimulator) — held against neck to stimulate vagus nerve; both acute and preventive use
• sTMS (single-pulse transcranial magnetic stimulation) — used at headache onset for acute treatment and daily for prevention

Lifestyle and Non-Pharmacological Strategies

Regular sleep schedule — irregular sleep is a major migraine trigger. Consistent bedtime and wake time, even on weekends, reduces migraine frequency significantly.

Regular meals and hydration — skipping meals drops blood sugar and is a reliable trigger. Staying well-hydrated (2+ liters/day) prevents dehydration-triggered attacks.

Regular aerobic exercise — 3 sessions of 40 minutes of moderate-intensity aerobic exercise per week reduces migraine frequency comparably to topiramate in a randomized trial, without the side effects. Exercise may initially trigger migraines in some — warm up slowly and stay hydrated.

Cognitive Behavioral Therapy (CBT) for headache — reduces both migraine frequency and pain intensity through stress management, biofeedback, and sleep improvement. Particularly valuable for chronic migraine with high psychological burden.

Magnesium supplementation — 400–600mg magnesium glycinate or oxide daily. Migraine patients have lower brain and serum magnesium levels; supplementation reduces attack frequency. Well-tolerated and inexpensive — one of the best-evidenced over-the-counter preventive options. Also recommended by the American Headache Society.

Riboflavin (vitamin B2) — 400mg daily. A 1998 study found it reduced migraine frequency by 50% in responders. Very well-tolerated. Urine turns bright yellow — harmless.

Coenzyme Q10 — 300mg daily showed migraine frequency reduction in a randomized trial. Mitochondrial function is hypothesized to play a role in migraine.

Medication Overuse Headache: A Critical Warning

Using acute migraine medication (triptans, NSAIDs, opioids, combination analgesics) on more than 10–15 days per month can cause medication overuse headache (MOH) — also called rebound headache. The brain adapts by becoming more pain-sensitive, creating a cycle where more medication is needed, which causes more headache, which requires more medication.

MOH is a major reason why migraine becomes chronic (15+ days/month). Treatment requires withdrawing the overused medication — a process that initially worsens headache for 2–4 weeks before improving. If you're using acute medications more than 2–3 days per week, discuss this with your neurologist and consider preventive therapy to break the cycle.

Frequently Asked Questions